TVM Capital Life Science Leads €23 Million Funding for Smart Reporting

TVM Capital Life Science announced a significant €23 million Series C financing for Smart Reporting, a leader in medical reporting technology focused on radiology and pathology. The funding, led by TVM along with Bayern Kapital and prior investors, aims to enhance Smart Reporting’s global presence, especially in markets like the US, Canada, Australia, and New Zealand. Dr. Hubert Birner, Managing Partner at TVM, will join Smart Reporting's board.

Smart Reporting has developed a manufacturer-independent, voice-controlled software that automates medical documentation, significantly streamlining physician workflows and generating usable data. This innovation is crucial as the number of radiologists diminishes. The company has also enriched its partnership with Solventum to advance radiology reporting technologies.

Both firms, describing the potential of AI and machine learning in healthcare, anticipate substantial growth and market leadership in medical reporting. With this investment, Smart Reporting plans to deepen its penetration in vital global healthcare IT markets using its AI-driven solutions. The company was lauded for its strong, commercially viable technology that directly enhances patient care.